Lv1
38 积分 2025-08-29 加入
A neomorphic protein interface catalyzes covalent inhibition of RASG12D aspartic acid in tumors
2天前
已完结
Efficacy and safety of gefapixant, a P2X3 receptor antagonist, in refractory chronic cough and unexplained chronic cough (COUGH-1 and COUGH-2): results from two double-blind, randomised, parallel-group, placebo-controlled, phase 3 trials
11个月前
已完结
皖公网安备34019202002308
